Cargando…

Proton Pump Inhibitor-Related Gastric Mucosal Changes

Proton pump inhibitors (PPIs) are used worldwide to treat of acid-related disorders such as peptic ulcer and gastroesophageal reflux disease and to prevent gastroduodenal injuries due to nonsteroidal anti-inflammatory drugs. PPIs are the most potent inhibitors of gastric acid secretion currently ava...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kim, Gwang Ha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444106/ https://www.ncbi.nlm.nih.gov/pubmed/32327613 http://dx.doi.org/10.5009/gnl20036

Ejemplares similares

Proton Pump Inhibitor-associated Mucosal Change
por: Kato, Mototsugu, et al.
Publicado: (2017)

The effect of proton pump inhibitors and vonoprazan on the development of ‘gastric mucosal redness’
por: Shinozaki, Satoshi, et al.
Publicado: (2022)

Proton pump inhibitor-induced fundic gland polyposis
por: Park, Young Joo, et al.
Publicado: (2017)

Influence of Proton Pump Inhibitors on Dexamethasone-Induced Gastric Mucosal Damage in Rats
por: Swamy, A. H. M. Viswanatha, et al.
Publicado: (2011)

Gastric mucosal prolapse: A case of proton‐pump inhibitor nonresponsive dyspepsia
por: Sunkara, Tagore, et al.
Publicado: (2018)

Effect of long-term proton pump inhibitor administration on gastric mucosal atrophy: A meta-analysis
por: Li, Zhong, et al.
Publicado: (2017)

The use of proton pump inhibitors in treating and preventing NSAID-induced mucosal damage
por: Scheiman, James M
Publicado: (2013)

Can Nocturnal Acid-breakthrough Be Reduced by Long-acting Proton Pump Inhibitors?
por: Jeon, Hye Kyung, et al.
Publicado: (2017)

Gastric Epithelial Cell Modality and Proton Pump Inhibitor
por: Masaoka, Tatsuhiro, et al.
Publicado: (2008)

Proton pump inhibitor alone vs proton pump inhibitor plus mucosal protective agents for endoscopic submucosal dissection-induced ulcer: a systematic review and meta-analysis
por: Nishizawa, Toshihiro, et al.
Publicado: (2015)

Clinical Predictors for Response to Proton Pump Inhibitor Treatment in Patients With Globus
por: Jeon, Hye Kyung, et al.
Publicado: (2013)

Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids—What Is the Relationship?
por: McCarthy, Denis M.
Publicado: (2020)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

Proton pump inhibitor: The dual role in gastric cancer
por: Joo, Moon Kyung, et al.
Publicado: (2019)

Use of proton pump inhibitors for the risk of gastric cancer
por: Gao, Huiqin, et al.
Publicado: (2022)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Science review: The use of proton pump inhibitors for gastric acid suppression in critical illness
por: Brett, Stephen
Publicado: (2005)

Immune checkpoint inhibitors and their interaction with proton pump inhibitors–related interstitial nephritis
por: Miao, Jing, et al.
Publicado: (2023)

Profile of the Change in Depression during Proton-Pump Inhibitor Therapy in Patients with Gastroesophageal Reflux Disease: Influence of the Mucosal Break
por: Wu, Chia-Liang, et al.
Publicado: (2021)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Management of laryngopharyngeal reflux with proton pump inhibitors
por: Reimer, Christina, et al.
Publicado: (2008)

Problems Associated with Deprescribing of Proton Pump Inhibitors
por: Helgadottir, Holmfridur, et al.
Publicado: (2019)

Proton Pump Inhibitor Induction of Gastric Cobblestone-like Lesions in the Stomach
por: Takahari, Kosuke, et al.
Publicado: (2017)

25 Years of Proton Pump Inhibitors: A Comprehensive Review
por: Strand, Daniel S., et al.
Publicado: (2017)

Proton pump inhibitors: A balanced view
por: Ramakrishna, B.S.
Publicado: (2015)

Mechanisms of proton pump inhibitor‐induced hypomagnesemia
por: Gommers, Lisanne M. M., et al.
Publicado: (2022)

Proton pump inhibitors and dementia: what association?
por: Caetano, Catarina, et al.
Publicado: (2023)

Long-term use of proton-pump inhibitors and risk of gastric cancer: a review of the current evidence
por: Cheung, Ka Shing, et al.
Publicado: (2019)

Use of Proton Pump Inhibitors and the Risk for the Development of Gastric Cancers: A Nationwide Population-Based Cohort Study Using Balanced Operational Definitions
por: Gong, Eun Jeong, et al.
Publicado: (2022)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

One way for the gastric proton pump
por: Nissen, Poul
Publicado: (2009)

Effect of a Proton Pump Inhibitor on Tumor Bleeding Prevention in Unresectable Gastric Cancer Patients: a Double-Blind, Randomized, Placebo-Controlled Trial
por: Kim, Young-Il, et al.
Publicado: (2017)

Antiplatelet agents and proton pump inhibitors – personalizing treatment
por: Lin, Eugene, et al.
Publicado: (2010)

Proton pump inhibitors for the treatment of cancer in companion animals
por: Walsh, Megan, et al.
Publicado: (2015)

Proton Pump Inhibitors: More Indigestion than Relief?
por: Malavade, P., et al.
Publicado: (2017)

Adverse Effects of Proton Pump Inhibitors—Evidence and Plausibility
por: Fossmark, Reidar, et al.
Publicado: (2019)

Esophageal Baseline Impedance Reflects Mucosal Integrity and Predicts Symptomatic Outcome With Proton Pump Inhibitor Treatment
por: Xie, Chenxi, et al.
Publicado: (2018)

Proton Pump Inhibitor Prophylaxis After Gastric Bypass Does Not Cause Hypomagnesemia
por: Boerlage, Thomas C. C., et al.
Publicado: (2016)

Effect of a Proton Pump Inhibitor on the Duodenum Microbiome of Gastric Ulcer Patients
por: Lim, Jung-Hyun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qbhg4545bds28d9pqlm6bkg2th